TACE (Transcatheter arterial chemoembolization)

PROCEDURE3 trials

Sponsors

Taipei Veterans General Hospital, Taiwan, Chung-Ang University, Ivy Life Sciences, Co., Ltd

Conditions

HepatoCellular CarcinomaHepatocellular CarcinomaLiver Cancer

Phase 2

Study in Asia of the Combination of TACE With Sorafenib in HCC Patients

Taipei Veterans General Hospital, TaiwanHepatocellular Carcinoma

Start: 2009-02-28Target: 36Updated: 2011-01-05

Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)

Chung-Ang UniversityHepatocellular Carcinoma

Start: 2009-06-30End: 2013-06-30Target: 63Updated: 2011-06-23

Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy

Ivy Life Sciences, Co., LtdHepatoCellular Carcinoma, Liver Cancer

Start: 2009-12-31End: 2021-08-31Target: 60Updated: 2020-04-16

Related Papers

The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in <scp>A</scp> sian patients with hepatocellular carcinoma: Final results of the <scp>START</scp> trial

International Journal of Cancer2014-08-05117 citations